z-logo
open-access-imgOpen Access
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective study
Author(s) -
Tianqing Chu,
Wei Zhang,
Bo Zhang,
Runbo Zhong,
Xueyan Zhang,
Aiqin Gu,
Chunlei Shi,
Huimin Wang,
Liwen Xiong,
Jun Lü,
Jianlin Qian,
Yanwei Zhang,
Yu Dong,
Jiajun Teng,
Zhiqiang Gao,
Weimin Wang,
Yinchen Shen,
Wei Nie,
Jeong Uk Lim,
Hiren J. Mehta,
Joel W. Neal,
Yuqing Lou,
Jianlin Xu,
Hua Zhong,
Baohui Han
Publication year - 2022
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr-22-438
Subject(s) - medicine , lung cancer , oncology , bioinformatics , cancer research , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom